In further support of this possibility, we have recently demonstrated that JNK is essential for the maintenance of the tumor-initiating capacity but not for the bulk tumor growth of A549 lung adenocarcinoma cells known to harbor an activating K-Ras mutation [54-56]. The gene discussed is KRAS; the disease is lung adenocarcinoma.